Page last updated: 2024-11-03

opc 12759 and Esophagitis, Reflux

opc 12759 has been researched along with Esophagitis, Reflux in 2 studies

rebamipide: structure in first source; RN refers to (+-)-isomer; inhibits gastric xanthine oxidase

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hong, SJ1
Park, SH1
Moon, JS1
Shin, WG1
Kim, JG1
Lee, YC1
Lee, DH1
Jang, JY1
Kim, JJ1
Lee, HL1
Lee, SW1
Hwangbo, Y1
Xu, J1
Wang, B1
Xue, Z1
Liu, F1
Yuan, Y1
Leelakusolvong, S1
Dy, F1
Katada, K1
Yoshida, N1
Isozaki, Y1
Tomatsuri, N1
Ichikawa, H1
Naito, Y1
Okanoue, T1
Yoshikawa, T1

Trials

1 trial available for opc 12759 and Esophagitis, Reflux

ArticleYear
The Benefits of Combination Therapy with Esomeprazole and Rebamipide in Symptom Improvement in Reflux Esophagitis: An International Multicenter Study.
    Gut and liver, 2016, Nov-15, Volume: 10, Issue:6

    Topics: Adult; Alanine; Drug Administration Schedule; Drug Therapy, Combination; Esomeprazole; Esophagitis,

2016

Other Studies

1 other study available for opc 12759 and Esophagitis, Reflux

ArticleYear
Prevention by rebamipide of acute reflux esophagitis in rats.
    Digestive diseases and sciences, 2005, Volume: 50 Suppl 1

    Topics: Acute Disease; Alanine; Animals; Anti-Ulcer Agents; Chemokine CXCL1; Chemokines, CXC; Esophagitis, P

2005